RCS - Intelligent Ultrasnd - SonoLystlive launched on Voluson Expert Series

Intelligent UltrasoundAnnouncement

11/09/2023 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230911:nRSK9391La&default-theme=true

RNS Number : 9391L  Intelligent Ultrasound Group PLC  11 September 2023

SonoLystlive, powered by Intelligent Ultrasound's ScanNav AI, launches on new
GE Healthcare Voluson Expert Series ultrasound machines

 

Intelligent Ultrasound Group plc (AIM: IUG), the 'classroom to clinic'
ultrasound company, specialising in artificial intelligence (AI) software and
simulation, announces that GE Healthcare has launched SonoLystlive onto its
latest version of the Voluson Expert Series portfolio of ultrasound machines.

 

Powered by Intelligent Ultrasound's ScanNav AI software, SonoLystlive takes
ultrasound image recognition to the next level by automatically capturing
images in real-time, as the clinician scans a mid-trimester patient. Using
practice guidelines from the International Society of Ultrasound in Obstetrics
and Gynecology (ISUOG), the AI software automatically recognises the anatomy,
captures the image and checks it off the list of required views. By minimising
the need to manually freeze, annotate and store images, the software
significantly reduces keystrokes and exam time for sonographers.

 

This new technology further builds on Intelligent Ultrasound's long-term
partnership agreement with GE HealthCare, which already incorporated
Intelligent Ultrasound's AI technology as an option add-on in its SonoLyst
X/IR software on the Voluson Expert 22 and SWIFT ultrasound machines.

 

SonoLystlive was demonstrated live at the International Symposium on Fetal
Anomalies in London, on the 9 and 10 September by Prof Aris Papageorghiou. The
full launch will take place at the ISUOG World Congress in Seoul, South Korea
from the 16-19 October.

 

Stuart Gall, CEO of Intelligent Ultrasound, commented:

"We are delighted that, by incorporating SonoLystlive onto its Voluson Expert
Series ultrasound machines 1  (#_ftn1) ,  GE Healthcare is leading the way in
using AI software to improve obstetric workflows for the benefit of clinicians
and patients. The Voluson Expert Series is a market-leading ultrasound machine
in the global women's healthcare obstetrics market and SonoLystlive is a
fantastic example of how AI software can help save scanning time, whilst
de-stressing the scanning environment for the sonographer.

 

We look forward to continuing our partnership with GE HealthCare and we remain
excited that our novel 'classroom-to-clinic' approach is making clinical
diagnostic ultrasound easier to learn and simpler to use."

 

This announcement contains inside information for the purposes of the UK
version of Article 7 of Regulation (EU) 596/2014.

 

ENDS

 

Enquiries:

 

 Intelligent Ultrasound Group plc  www.intelligentultrasound.com (http://www.intelligentultrasound.com)
 Stuart Gall, CEO                  Tel: +44 (0)29 2075 6534
 Helen Jones, CFO

 Cenkos Securities                 Tel:  +44 (0)20 7397 8900
 Giles Balleny / Dan Hodkinson (Corporate Finance)
 Dale Bellis / Julian Morse (Sales)

 

 

  TB Cardew - PR Advisors   Intelligentultrasound@tbcardew.com (mailto:Intelligentultrasound@tbcardew.com)

  Ed Orlebar                Tel: +44 (0)7738 724630
  Allison Connolly                                                    Tel: +44 (0)7587 453955
  Emma Pascoe-Watson                                                  Tel: +44 (0)7774 620415
  Hero Kurzeja                                                        Tel: +44 (0)7827 130430

 

 

About Intelligent Ultrasound Group

Intelligent Ultrasound (AIM: IUG) is one of the world's leading 'classroom to
clinic' ultrasound companies, specialising in real-time hi-fidelity virtual
reality simulation for the ultrasound training market ('classroom') and
artificial intelligence-based clinical image analysis software tools for the
diagnostic medical ultrasound market ('clinic'). Based in Cardiff in
the UK and Atlanta in the US, the Group has two revenue streams:

 

Simulation

Real-time hi-fidelity ultrasound education and training through simulation.
Our main products are the ScanTrainer obstetrics and gynaecology training
simulator, the HeartWorks echocardiography training simulator,
the BodyWorks Eve Point of Care and Emergency Medicine training simulator
with Covid-19 module and the new BabyWorks Neonate and Paediatric training
simulator. To date over 1,500 simulators have been sold to over 750 medical
institutions around the world.

 

Clinical AI software

Deep learning-based algorithms to make ultrasound machines smarter and more
accessible using our proprietary ScanNav ultrasound image analysis technology.
Current products on the market utilising this technology are GE
Healthcare's SonoLyst software that is incorporated in their Voluson Expert
Series and SWIFT ultrasound machines; ScanNav Anatomy PNB that simplifies
ultrasound-guided needling by providing the user with real-time AI-based
anatomy highlighting for a range of medical procedures; and NeedleTrainer
that teaches real-time ultrasound-guided needling and incorporates ScanNav
Anatomy PNB.

 

www.intelligentultrasound.com (http://www.intelligentultrasound.com/)

 

NOTE: ScanNav Anatomy PNB is CE approved and cleared for sale in the US by the
FDA, but is not available for sale in any other territory requiring government
approval for this type of product.

 

 

 1  (#_ftnref1) Voluson Expert E22 and E20

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  NRADDGDCXBBDGXG